Expression of Inhibitory Receptors in Natural Killer (CD3−CD56+) Cells and CD3+CD56+ Cells in the Peripheral Blood Lymphocytes and Tumor Infiltrating Lymphocytes in Patients with Primary Hepatocellular Carcinoma-Reference-Cited by-同舟云学术

Expression of Inhibitory Receptors in Natural Killer (CD3−CD56+) Cells and CD3+CD56+ Cells in the Peripheral Blood Lymphocytes and Tumor Infiltrating Lymphocytes in Patients with Primary Hepatocellular Carcinoma

Published:2001-12 Issue:3 Volume:101 Page:264-269
ISSN:1521-6616
Container-title:Clinical Immunology
language:en
Short-container-title:Clinical Immunology

Author:

Yuen Man-Fung,Norris Suzanne

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference20 articles.

1. Killer cell inhibitory receptors: Diversity, specificity, and function;Long;Immunol. Rev.,1997

2. Natural killer cell activation and inhibition by receptors for MHC class I;Lopez-Botet;Curr. Opin. Immunol.,1999

3. Natural killer cell receptors;Yokoyama;Curr. Opin. Immunol.,1998

4. HLA class I specific inhibitory receptors;Moretta;Curr. Opin. Immunol.,1997

5. The human liver contains multiple populations of NK cells, T cells, and CD3+CD56+ natural T cells with distinct cytotoxic activities and Th1, Th2, and Th0 cytokine secretion patterns;Doherty;J. Immunol.,1999

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Phenotypic and functional exhaustion of circulating CD3⁺CD56⁺NKT‐like cells in colorectal cancer patients;The FASEB Journal;2024-03-02

2. Protein O-GlcNAcylation in multiple immune cells and its therapeutic potential;Frontiers in Immunology;2023-08-22

3. Single‐cell transcriptomic landscape reveals the differences in cell differentiation and immune microenvironment of papillary thyroid carcinoma between genders;Cell & Bioscience;2021-02-15

4. PD-1 blockade improves the anti-tumor potency of exhausted CD3+CD56+ NKT-like cells in patients with primary hepatocellular carcinoma;OncoImmunology;2021-01-01

5. Immunotherapy in hepatocellular carcinoma: the complex interface between inflammation, fibrosis, and the immune response;Journal for ImmunoTherapy of Cancer;2019-10-18